FP

Frank P.

Vice President, Strategy And Business Development at Editas Medicine

Frank P. has extensive experience in strategy, business development, and mergers and acquisitions. Frank is currently the Vice President of Strategy and Business Development at Editas Medicine, a genome editing company focused on developing treatments for serious diseases. Prior to this, Frank held positions such as Senior Vice President and Global Head of Mergers and Acquisitions at Lumanity, Senior Vice President of Strategy and Corporate Development at Parexel, and Managing Director at Boston Meridian LLC, an investment bank. Frank also worked as a Partner & Advisor at KBT Partners, Vice President at Fidelity Ventures, Associate at Jefferies Broadview, and Financial Analyst at ING Barings. Frank has a strong background in the healthcare industry and has contributed to over $10 billion in completed M&A transactions throughout their career.

Frank P. attended Boston College High School from 1989 to 1993. Frank completed their undergraduate studies at Harvard University from 1993 to 1997, earning a Bachelor of Arts degree in Economics. Frank later pursued their Master of Business Administration (MBA) at Harvard Business School from 2001 to 2003.

Location

Cambridge, United States

Links

Previous companies


Org chart


Teams


Offices


Editas Medicine

5 followers

Editas Medicine is a leading genome editing company focused on translating the power and promise of our proprietary genome editing systems into medicines to help transform the lives of people with genetically-defined diseases. Their goal is to discover, develop, manufacture, and commercialize transformative medicines for a range of serious diseases, including eye diseases, blood diseases, and cancer.


Industries

Employees

201-500

Links